155 results
Page 5 of 8
8-K
EX-99.1
meyuucpb3 cbsvqens
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
bmn3e
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
u3h7h6y2ypp plnn
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.2
plgr8g7m4 lj
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-1.1
dr4pa9d4pi5c
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.1
frg89kmx192s9er0nuq
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
u6x41n28j
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
0y6vd9nb8 33
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
74s39
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
EX-99.2
nq9d0doq79w8omu
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
8-K
EX-99.1
129eg
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
mo1bk
18 Mar 20
Automatic shelf registration
10:00pm
8-K
EX-99.1
0jbwip
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.2
uehf05fcy8d3xhb6tz
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
8-K
EX-99.1
ehi77x
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm